Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI PET/CT in Keloid
NCT05275699Phase 2Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Mar 2022
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Peking Union Medical College Hospital. Primary endpoint: Diagnostic value at 1 year. Started Mar 2022; status: completed.
Beyond the preview
Go deeper on NCT05275699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05275699.